How about a product that’s not only stronger than the pre-2004 hormonals, but is also scientifically proven to be able to be more myotropic (muscle building) than Anadrol, Testosterone Propionate, Winstrol, and Methyl-Testosterone (4 of the most potent illegal steroids known)? How about a product that will increase muscle hardness, definition, and give unheard of mass gains at the same time? How about a product that can give users an unimaginable “alpha-male” feeling and can give all of these amazing gains with little to no liver impact, as well as absolutely 0 estrogen worries?

Dymethazine is a designer anabolic that gives massive gains in size and strength without the harsh side effects associated with other hormonal products. Dymethazine consists of 2 molecules joined together by an azine bond.  Once metabolized, the molecules split, leaving one in its original form and one with an azine bond which creates a hydrazone. This hydrazone attachment is the secret to the unique properties that Dymethazine has, unlike any other hormonal product on the market. Dymethazine was clinically proven to have the HIGHEST myotropic (muscle building) effects out of Methyltestosterone, Oxymethalone, Androstanazole and Testosterone Propionate.

What is "Azine Bond Technology?"
Azine Bond Technology is what makes Dymethazine unique. It is a bond that links the 2 molecules of Dymethazine together.  This azine bond creates a “time release” effect.

Because of the time release the liver is spared much of the damage that normal methylation creates. Clinical studies have shown that Dymethazine has little to no effect on liver enzymes.

The azine bond also decreases the chances of “ HPTA shutdown.”  If your bodies natural testosterone production is shut down it can impact your gains, mood, and libido both on your cycle and during PCT.

Azine Bond Technology enables users to run cycles of up to 6 weeks. This is because of the reduced liver toxicity and mild impact on the HPTA.

Clinical Evidence
Study 1: Biological activity of dimethazine in the protein-anabolic field. Matscher, R.; Lupo, C.; De, P. Ruggieri. Lab. Ric. Ormonoter. Richter, Milan, Bollettino - Societa Italiana di Biologia Sperimentale (1962), 38 988-90. CODEN: BSIBAC ISSN: 0037-8771. Journal language unavailable. CAN 58:34623 AN 1963:34623 CAPLUS

Abstract: Dimethazine was compared to methyltestosterone, oxymethalone, androstanazole and testosterone propionate in its protein-anabolic activity. The tests were made on castrated rats with a single hypodermic injection of 250 , on young male and female rats with increasing daily oral doses from 100 to 1000 for 30 days, and on adult male rats with daily oral doses of 1000 for 25 days. It was shown that I did not interfere with the growth of young animals; that adult rats treated with I gained, on an av., 20 g. more in wt. than the controls; and that I had a greater myotropic effect on castrates than the other steroids, and induced a higher N retention than methyltestosterone in adult males.

Conclusion: This study indicates that Dymethazine possesses the capability of delivering a higher myotropic (muscle-building) effects than conventional illegal steroids such as testosterone propionate, anadrol, and winstrol.

Study 2: Antigonadotropic action of a new steroid with anabolizing activity studied in the anterior pituitary gland of the castrated rat Author Beghelli, V.; Mavrulis, A. Organization Univ. Bologna, Italy Publication Source Biochimica Applicata (1962), 9(No. 4), 179-88 Identifier-CODEN BIALAY ISSN 0006-298

Abstract: Seventy-five female rats were divided into 5 groups; 15 served as controls; 60 were castrated and among these, 15 were treated with 17.alpha.-ethyl-19-nortestosterone (I), 15 with 17.alpha.-methyl-17.beta.-hydroxyandrosta-1,4-dien-3-one (II), and 15 with 2.alpha.,(Dimetazine) (III). With each of these steroids, treatment began 48 hrs. after the operation, with 1 mg. of the drug suspended in 0.5 ml. of saline (1% Tween 80 as suspending agent) once daily for 20 days by gavage. The last 15 received the vehicle only, according to the same schedule. The rats were sacrificed 24 hrs. after the last dose, and their pituitary glands and uteri examd. The castrates which received the vehicle only showed very pronounced gonadotropic pituitary hyperfunction, such as formation of castration cells and an increase in basophilic cells. Animals treated with I showed no castration cells at all, and only a small increase in basophilic cells. Those given II had some castration cells, and only a moderate redn. of basophilic cells compared with the untreated rats. The effect of III on the pituitary was almost negligible. In uterotropic activity, measured as the ratio of uterus wt. to body wt., I was most effective; III was intermediate; II showed almost no activity.

Conclusion: This study showed little to no impact on the HPTA.  This means that you will not experience the “shutdown” effect that is common to anabolics.  This makes it easier to keep your gains in size and strength when your cycle is over.

Study 3:  Secondary hormone effects of gynecological interest of dimetazine Author Pasquinucci, Cesare Organization Univ. Milan Publication Source Annali di Ostetricia e Ginecologia (1962), 84, 851-67 Identifier-CODEN AOGIAI ISSN 0003-4657

Abstract: In a group of 10 women in surgical menopause a colpocytological study showed that dimetazine had no estrogenic or androgenic activity. In cases where a previous estrogenation had taken place, the drug had a slightly antiestrogen activity. In a group of fertile patients with normal ovarian cycle, the treatment had no effect on the cycle characteristics
Conclusion: This study shows that Dymethazine has no estrogenic or negative androgenic side effects.  This means that you don’t have to worry about side effects such as bloating, fat gain, etc and all of your gains will be hard, lean, and dry.

Study 4:  Protracted action of protein anabolism in gynecological oncology and its effect on hepatic function. Dambrosio, F.; Donatelli, G. Fontana. Univ. Milan, Cancro, Il (1963), 16(5), 553-604. Journal language unavailable. CAN 62:11656 AN 1965:11656 CAPLUS

Abstract: Twenty mg. of Dymethazine, an anabolizing steroid, was administered daily for 45-95 days to 11 gynecological patients. More than 50% of the cases showed no change in the bilirubinemia, the others showed modest to moderate increases. The glutamic-oxalacetic and the glutamic-pyruvic transaminases of the serum increased greatly in 3 patients. The albumins concn. usually decreased in the course of the treatment, while the globulins concn. did not change.

Conclusion: This study shows that Dymethazine can be used safely from 45-60 days at the reccommended dosage.